Connor, Clark & Lunn Investment Management (CC&L)’s AtriCure ATRC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.85M	Sell	345,388 -33,108	-9%	-$1.13M	0.02%	474
2025 Q4	$15M	Buy	378,496 +27,218	+8%	+$998K	0.04%	353
2025 Q3	$12.4M	Buy	351,278 +86,934	+33%	+$3M	0.04%	364
2025 Q2	$8.66M	Buy	264,344 +40,775	+18%	+$1.33M	0.03%	432
2025 Q1	$7.21M	Buy	223,569 +41,847	+23%	+$1.55M	0.03%	401
2024 Q4	$5.55M	Sell	181,722 -4,097	-2%	-$132K	0.03%	457
2024 Q3	$5.21M	Buy	185,819 +52,533	+39%	+$1.29M	0.03%	421
2024 Q2	$3.03M	Buy	133,286 +56,380	+73%	+$1.3M	0.01%	546
2024 Q1	$2.34M	Buy	76,906 +40,559	+112%	+$1.36M	0.01%	626
2023 Q4	$1.3M	Buy	36,347 +16,259	+81%	+$605K	0.01%	782
2023 Q3	$880K	Sell	20,088 -39,560	-66%	-$1.93M	﹤0.01%	857
2023 Q2	$2.94M	Buy	59,648 +16,033	+37%	+$739K	0.01%	506
2023 Q1	$1.81M	Buy	43,615 +15,361	+54%	+$637K	0.01%	578
2022 Q4	$1.25M	Buy	28,254 +14,766	+109%	+$617K	0.01%	660
2022 Q3	$527K	Buy	+13,488	New	+$617K	﹤0.01%	808
2021 Q3	–	Sell	-6,426	Closed	-$510K	–	1030
2021 Q2	$510K	Buy	+6,426	New	+$467K	﹤0.01%	785
2018 Q4	–	Sell	-6,000	Closed	-$210K	–	942
2018 Q3	$210K	Buy	+6,000	New	+$190K	﹤0.01%	845